Sedgefield, UK. October 2012 – Reinnervate Ltd, the developers of Alvetex®Scaffold for 3D cell culture, today announced the launch of a new 3D cell culture portal for scientists in the life science sector. The new resource brings together a wide variety of information, protocols, peer-reviewed papers and videos to help not only those who are considering the adoption of 3D cell culture but also those already using this approach to growing cells in vitro.
‘We have created a central resource that will help scientist to learn why 3D cell culture may be beneficial, how they can evaluate 3D cell culture and how to pick the right type of Alvetex®Scaffold format for their experiments’ commented Barry Lynch, Marketing Manager at Reinnervate Ltd. ‘We are highlighting independent publications, testimonials from scientists already growing cells in 3D, validated protocols and videos showing how different 3D technologies stack up’, he added.
To support the launch of the new 3D cell culture resource, Reinnervate will run a series of webinars describing detailed scientific data comparing 3D and 2D cell culture experiments in the areas of;
- Assessment of Cancer cell cytotoxicity in a novel 3D culture assay (9th Oct 2012)
- Formation of Mesenchymal tissues in Alvetex®Scaffold derived from stem cells and other established cell lines (7th Nov 2012)
- Modelling cancer cell invasion using novel technology for 3D cell culture (5th Dec 2012)
- Full details can be found at www.reinnervate.com/campaign
Alvetex®Scaffold is a unique polystyrene material that provides a robust and inert scaffold for cells to grow and form complex 3D structures in the laboratory, mimicking the normal growth and formation of tissues in the body. Reinnervate has extensively tested and validated Alvetex®Scaffold with a large number of cell types, including liver, skin, cancer and stem cells, all of which have important applications in basic research into cell development, disease modelling and drug safety screening.
Alvetex®Scaffold has been launched globally in several formats: a 12-well culture plate, 6-well and 12-well inserts and a deep petri dish. These formats provide researchers with an exceptional degree of versatility in how they choose to construct different 3D cell culture models. Through enabling alternative applications, such as long-term 3D cell culture over several weeks, 3D cell growth at air/liquid interface and 3D cell growth with different media constituents, to be performed simply and routinely, reinnervate continues to make genuine 3D cell culture a reality for researchers today.
Alvetex®Scaffold was voted as one of the top 100 innovative products of 2011 at the R&D 100 awards and was named among the winners of The Scientist magazine’s “Top 10 Life Science Innovations of 2010”.
See the company video - http://www.reinnervate.com/alvetex/videos
Reinnervate is an innovative life sciences company dedicated to making routine 3D cell culture a reality for researchers in academia and in the pharmaceutical and related industries.
Reinnervate’s core technology is Alvetex®Scaffold, a unique and proprietary scaffold that enables routine 3D cell culture in the laboratory. Alvetex provides a nanoscale environment that supports genuine homogeneous 3D cell growth. Cells grown using alvetex form complex 3D tissue cultures which more closely mimic normal in-vivo cell growth and the formation of tissues in the body than conventional techniques. The use of alvetex-derived 3D cell cultures can provide researchers with greater insight into how cells behave in the body in response to external factors (such as drug candidates) than is currently possible with existing 2D or other emerging 3D cell culture technologies.
Reinnervate has generated significant data, which have been published extensively in peer-reviewed publications, exemplifying the use of alvetex in a large number of cell types and applications. Alvetex®Scaffold has been launched globally in several formats: a 12-well culture plate, 24-well plate, 6-well and 12-well inserts and a deep well petri dish.
Reinnervate continues to develop its technology for use in the 3D cell culture. During 2012 Reinnervate will deliver further innovative products to help researchers improve the growth and function of their cultured cells
Reinnervate was founded in 2002 based on the pioneering research of Professor Stefan Przyborski and his lab at Durham University, UK, and is funded by NorthStar Equity Investors (NSEI), management and private investors.
For further information, please contact
Chief Executive Officer
+44 (0)1740 625266